About this trial
The goal of this clinical trial is to conduct MRI studies on adults with myofascial pain syndrome (MPS) to identify important MRI biomarkers that respond to OMT (osteopathic manipulation therapy) and investigate the feasibility of implementing MRI study and OMT in this population. The main outcomes of the study include:
* Determine whether biomarkers measured by MRI can differentiate normal tissues and MTrP (myofascial trigger point). * Test the responsiveness of the biomarkers identified by MRI to the proposed intervention, OMT, in patients with MPS of the upper back.
Researchers will compare participants who will receive one session of OMT (Group 1 - Experimental Condition) and participants who will not receive any treatment (Group 2 - Control Condition) to see how the MRI-identified biomarkers respond to the intervention.
Participants will complete the following:
* Clinical screening * MRI measures * Battery of self-report surveys * Clinical/Physical Function Assessment
Eligibility criteria
Qualifiers
MPS of the upper back with MTrPs as specified by Travell and Simons, with the confirmation of ultrasound procedure.
Normal neurological examination including manual muscle testing, sensory exam, and deep tendon reflexes.
English-speaking.
Age 18 - 64 and reside in the community.
Disqualifiers
Malignancy.
Major psychiatric disorders, such as bipolar disorder and depression.
Cognitive impairment
Skin lesion(s) on the shoulders and upper back.
Trial design
Treatments tested in this trial
- Osteopathic Manipulation Treatment - Scapular Release
Treatment groups
Locations
Sponsors and collaborators
Auburn University
Lead sponsor
Auburn University MRI Research Center
Collaborator
Edward Via College of Osteopathic Medicine-Auburn
Collaborator